Milan - Delayed Quote • EUR Sanofi (1SAN.MI) Follow Add holdings 85.94 -1.37 (-1.57%) At close: 5:35:09 PM GMT+2 Comparisons Indicators Technicals Corporate Events Draw List View Grid View Detach Attach No Tool Measure Undo Redo All All Favorites Text Statistics Technicals Fibonacci Markings Lines Annotation Arrow Line Horizontal Vertical Rectangle Trend Line Measurement Line Average Line Callout Channel Check Continuous Crossline Elliott Wave Ellipse Doodle Fib Projection Fib Arc Fib Fan Fib Time Zone Focus Gann Fan Gartley Heart Pitchfork Quadrant Lines Ray Regression Line Fib Retracement Star Speed Resistance Arc Speed Resistance Line Time Cycle Tirone Levels Volume Profile Cross Magnet Clear All Drawings Restore Default Parameters Loading Chart for 1SAN.MI 1D 5D 1M 3M 6M YTD 1Y 5Y All Date Range 1 min Recent News: 1SAN.MI View More All News Press Releases SEC Filings M&A is 'lifeblood' of biopharma: Analyst on Sanofi-Blueprint deal Sanofi to acquire Blueprint Medicines, Boeing upgrade Sanofi Just Spent $9.5 Billion on a Rare Disease You've Never Heard Of Sanofi Signs a $9.5B Agreement to Acquire Blueprint Medicines Top Midday Stories: Steel Stocks Soar After Trump Doubles Steel Tariffs; Bristol Myers Squibb, BioNTech to Collaborate on Tumor Therapy Sanofi to expand immunology offerings with Blueprint Medicines Blueprint Medicines Soars 26% on $9.5 Billion Buyout. Why This Drug Is Key to the Deal. Sanofi to Acquire Blueprint Medicines for up to $9.5 Billion to Expand Immunology Portfolio Blueprint Medicines Stock Soars as Biotech Agrees to Over $9B Sanofi Takeover Sanofi Expands Rare Immunology Portfolio With Blueprint Buyout Sanofi to acquire Blueprint for up to $9.5B Related Tickers LLY.MU Eli Lilly and Co 645.20 +0.99% AZNCF AstraZeneca PLC 142.50 +0.71% 1BAYN.MI Bayer Aktiengesellschaft 25.14 +1.58% NOV.DE Novo Nordisk A/S 63.40 +1.73% GILD Gilead Sciences, Inc. 108.67 -1.28% NVO Novo Nordisk A/S 72.44 +1.33% PFE Pfizer Inc. 23.41 -0.26%